NCT04459078 2022-12-02
Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Hunan Cancer Hospital
Phase 2 Unknown
Hunan Cancer Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences